Abstract
The ranking and prediction of novel therapeutic categories for existing drugs (drug repositioning) is a challenging computational problem involving the analysis of complex chemical and biological networks. In this context we propose a novel semi-supervised learning problem: ranking drugs in integrated bio-chemical networks according to specific DrugBank therapeutic categories. To deal with this challenging problem, we designed a general framework based on bipartite network projections by which homogeneous pharmacological networks can be combined and integrated from heterogeneous and complementary sources of chemical, biomolecular and clinical information. Moreover, we propose a novel method based on kernelized score functions for fast and effective drug ranking in the integrated pharmacological space. Results with 51 therapeutic DrugBank categories involving about 1300 FDA approved drugs show the effectiveness of the proposed approach.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
DiMasi, J., et al.: New drug development in the United States from 1963 to 1999. Clinical Pharmacology and Therapeutics 69(5), 186–196 (2001)
Ashburn, T., et al.: Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews 3(8), 28–55 (2004)
DiMasi, J., et al.: The price of innovation: new estimates of drug development costs. Journal of Health Economics 22(2), 151–185 (2003)
Anand, G.: How drug’s rebirth as treatment for cancer fueled price rises: once-demonized thalidomide boosts celgene’s sales; patients see costs soar. The Wall Street Journal 15(A1) (2004)
Noeske, T., Sasse, B., Strak, H., et al.: Predictiong compound selectivity by self-organizing maps: cross-activities of metabotropic glutamate receptor antagonists. Chem. Med. Chem. 1, 1066–1068 (2006)
Wei, G., Twomey, D., Lamb, J., et al.: Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10, 331–342 (2006)
Kotelnikova, E., Yuryev, A., Mazo, I., Daraselia, N.: Computational approaches for drug repositioning and combination therapy design. Journal of Bioinformatics and Computational Biology 8, 593–606 (2010)
Li, J., Zhu, X., Chen, J.: Building disease-specific drug-protein connectivity maps from molecular interaction networks and pubmed abstracts. PLoS Computational Biology 5, e1000450 (2009)
Lamb, J., et al.: The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795), 1929–1935 (2006)
Iorio, F., Bosotti, R., Scacheri, E., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., di Bernardo, D.: Discovery of drug mode of action and drug repositioning from transcriptional responses. PNAS 107(33), 14621–14626 (2010)
Gottlieb, A., Stein, G., Ruppin, E., Sharan, R.: PREDICT, a method for inferring novel drug indications with application to personalized medicine. Molecular Systems Biology 7, 496 (2011)
Sirota, M., et al.: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 96(3), 96–97 (2011)
Keiser, M., Setola, V., Irwin, J., et al.: Predicting new molecular targets for known drugs. Nature 462, 175–181 (2009)
Yamanishi, Y., Kotera, M., Kaneisha, M., Goto, S.: Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics (ISMB) 26, 246–254 (2010)
Chiang, A., Butte, A.: Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin. Pharmacol. Ther. 86, 507–510 (2009)
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., Djoumbou, Y., Eisner, R., Guo, A., Wishart, D.: DrugBank 3.0: a comprehensive resource for ’omics’ research on drugs. Nucleic Acids Res. 39, D1035–D1041 (2011)
Dudley, J., Desphonde, T., Butte, A.: Exploiting drug-disease relationships for computational drug repositioning. Briefings in Bioinformatics 12(4), 303–311 (2011)
Smola, A.J., Kondor, R.: Kernels and Regularization on Graphs. In: Schölkopf, B., Warmuth, M.K. (eds.) COLT/Kernel 2003. LNCS (LNAI), vol. 2777, pp. 144–158. Springer, Heidelberg (2003)
Kuhn, M., von Mering, C., Campillos, M., Jensen, L., P. B.: STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 36, D684–D688 (2008)
Gong, L., et al.: PharmGKB: an integrated resource of pharmacogenomic data and knowledge. Curr. Protoc. Bioinformatics 14(17) (2008)
Davis, A., et al.: The Comparative Toxicogenomics Database: update 2011. Nucleic Acids Res. 39, D1067–D1072 (2011)
Nikolova, N., Jaworska, J.: Approaches to measure chemical similarity - a review. QSAR Comb. Sci. 22(9-10), 1006–1026 (2003)
Weininger, D.: Smiles, a chemical language and information system. Journal of Chemical Information and Modeling 28(31) (1988)
Kuhn, M., Szklarczyk, D., Franceschini, A., Campillos, M., von Mering, C., Jensen, L., Beyer, A., Bork, P.: STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res. 38, D552–D556 (2010)
Lovasz, L.: Random Walks on Graphs: a Survey. Combinatorics, Paul Erdos is Eighty 2, 1–46 (1993)
Lippert, G., Ghahramani, Z., Borgwardt, K.: Gene function prediction from synthetic lethality networks via ranking on demand. Bioinformatics 26(7), 912–918 (2010)
Sandyk, R., Fisher, H.: L-tryptophan supplementation in parkinson’s disease. Int. J. Neurosci. 45((3-4), 215–219 (1989)
MacDonald, R., Jeffery, L.: Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones. Nature 271, 563–564 (1976)
Hanson, S., Czajkowski, C.: Structural mechanisms underlying benzodiazepine modulation of the GABA A receptor. The Journal of Neuroscience 28(13), 3490–3499 (2008)
Kuhn, M., Campillos, M., Letunic, I., Jensen, L., P., B.: A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6(343) (2010)
Croft, D., O’Kelly, G., Wu, G., Haw, R., Gillespie, M., Matthews, L., Caudy, M., Garapati, P., et al.: Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res. 39, D691–D697 (2010)
Woollard, P., Mehta, N., Vamathevan, J., Van Horn, S., Bonde, B., Dow, D.: The application of next-generation sequencing technologies to drug discovery and development. Drug Discovery Today 16(11-12), 512–519 (2011)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Re, M., Valentini, G. (2012). Large Scale Ranking and Repositioning of Drugs with Respect to DrugBank Therapeutic Categories. In: Bleris, L., Măndoiu, I., Schwartz, R., Wang, J. (eds) Bioinformatics Research and Applications. ISBRA 2012. Lecture Notes in Computer Science(), vol 7292. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30191-9_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-30191-9_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30190-2
Online ISBN: 978-3-642-30191-9
eBook Packages: Computer ScienceComputer Science (R0)